Assessing Biosimilarity using FunctionalMetrics
share
In recent years there have been a lot of interest to test for similarity between biological drug products, commonly known as biologics. Biologics are large and complex molecule drugs that are produced by living cells and hence these are sensitive to the environmental changes. In addition, biologics usually induce antibodies which raises the safety and efficacy issues. The manufacturing process is also much more complicated and often costlier than the small-molecule generic drugs. Because of these complexities and inherent variability of the biologics, the testing paradigm of the traditional generic drugs cannot be directly used to test for biosimilarity. Taking into account some of these concerns we propose a functional distance based methodology that takes into consideration the entire time course of the study and is based on a class of flexible semi-parametric models. The empirical results show that the proposed approach is more sensitive than the classical equivalence tests approach which are usually based on arbitrarily chosen time point. Bootstrap based methodologies are also presented for statistical inference.
READ FULL TEXT